REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 7.80
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 0.70 (8.974%)
Open: 8.15
High: 8.15
Low: 8.15
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Production and Testing of µSaltTM

4 Jan 2017 07:00

RNS Number : 2511T
Tekcapital plc
04 January 2017
 
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)

 

Tekcapital plc

("Tekcapital" or "the Company")

 

Successful Production and Independent Testing of µSaltTM

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces a successful test-production and independent taste testing of µSaltTM, its proprietary, low-sodium salt product.

 

Successful Taste Tests

Tekcapital has manufactured test quantities of µSaltTM in a current Good Manufacturing Practice ("cGMP") facility regulated by the US Food and Drug Administration. Test quantities of µSaltTM were then supplied to several organisations for independent testing and evaluation. The results of the study indicate that a taste test of traditional potato chips versus those salted with µSaltTM, with approximately 40% less sodium than traditional potato chips, yielded no statistically significant difference in perceived salt flavour.

 

Technology Background

In 2016, Tekcapital announced that it acquired US patent #8,900,650 B1 for low-sodium salt compositions, which has the potential to enable the commercialisation of a 1:1 replacement for regular salt in a variety of applications including table-top, dry snacks such as chips and crisps, popcorn, cereals, and other dry surface applications that have salt in spice mixes.

 

Regular 'table salt' is not readily soluble in saliva because of its high density and large particles size. When regular salt particles are sprinkled on foods for immediate consumption or during further processing, they tend to provide low-intensity and long-lasting spotty salty tastes. The µSaltTM technology aims to deliver an improved dissolution, providing an equally salty taste as table salt with lower salt concentrations.

 

This innovative 'microsalt' does not contain substitutes like calcium, potassium or magnesium salts, which can impart the bitter taste that is typical of many existing low-sodium salt products. Furthermore, these nano particles dissolve faster and are tasted faster by the consumer, thereby allowing for the reduction of the concentration of salt in dry snacks where salt and spices are applied to the surface.

 

Key features of a commercialised version of this salt preparation would include, but may not be limited to, co-blending with spices, flavours, colours and flow agents and increasing salt dispersion while enhancing salt sensation in the mouth.

 

Market Potential

According to market research firm IBISWorld Inc., sales of table salt in the United States in 2013 were approximately $598.7 million1. Based on the recently completed results from an independent university test, the Directors believe that its µSaltTM low-sodium technology could enable food companies to empower consumers to reduce sodium content in topical food applications without sacrificing taste. Furthermore, the Directors believe that this will be helpful in enabling individuals to seek to reduce their sodium consumption to less than or equal to 2,300 mg per day, as recommended in the 2015-2020 Dietary Guidelines for Americans2.

 

 

 

Commenting on the announcement, Clifford M. Gross, Ph.D., Executive Chairman of Tekcapital plc, said:

"We are excited to report that we have produced and tested our natural µSaltTM product and have found that it provides a level of taste similar to traditional salt, but with approximately 40% less sodium. If widely adopted, we believe that the potential positive impact to improving the health of consumers could be significant. We are currently in discussions with a number of leading companies regarding commercialisation of this exciting new product and we will update the market in due course."

 

 

 

 

For further information, please contact:

 

Tekcapital Plc

+1 305 200 3450

Clifford M. Gross, Ph.D.

info@tekcapital.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 

+44 (0)20 3328 5656

Jeremy Porter / Alex Brearley

 

 

 

Optiva Securities Limited (Joint Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

 

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen

tekcapital@walbrookpr.com

 

Notes

----------------------------------------------------

1. http://www.prweb.com/releases/2013/8/prweb11061887.htm 

2. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm494732.htm#ftn9

 

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUGUWWGUPMGMW
Date   Source Headline
20th May 20201:51 pmRNSNotification Of Major Shareholding
19th May 202012:07 pmRNSResult of GM and Completion of Fundraise
6th May 20207:00 amRNSFinal Results
1st May 20207:00 amRNSConditional Placing to raise £925,000
29th Apr 202011:05 amRNSSecond Price Monitoring Extn
29th Apr 202011:00 amRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSLucyd expands online presence to Walmart.com
21st Apr 20202:35 pmRNSCorrection : Total Voting Rights
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSMarket Research Report: Belluscura plc
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
9th Apr 20203:27 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSPortfolio Company Update : Guident
2nd Apr 20207:00 amRNSMexico adopts new Sodium reduction guidelines
30th Mar 20202:54 pmRNSHolding(s) in Company
27th Mar 202012:45 pmRNSHolding(s) in Company
26th Mar 20208:00 amRNSPortfolio Company Update:
26th Mar 20207:00 amRNSPortfolio Company Update: Lucyd
24th Mar 20207:00 amRNSSalarius confirms store roll out
23rd Mar 20202:59 pmRNSPortfolio Company Update
23rd Mar 202010:56 amRNSHolding(s) in Company
16th Mar 20209:15 amRNSBelluscura plc filing of a patent
4th Mar 20207:00 amRNSSalarius secures contract sales partner
2nd Mar 20207:00 amRNSSalarius North American distribution agreement
28th Feb 20207:00 amRNSTotal Voting Rights
12th Feb 20203:09 pmRNSHolding(s) in Company
10th Feb 20202:12 pmRNSHolding(s) in Company
10th Feb 20207:00 amRNSStrategy/Company/Ops Update
7th Feb 20204:03 pmRNSHolding(s) in Company
6th Feb 202012:45 pmRNSPlacing to raise £740,000
24th Jan 20207:00 amRNSSalarius new major food contract
20th Jan 20207:00 amRNSLucyd launch of new bluetooth-enabled Glasses
16th Jan 20207:00 amRNSExhibit At AUTM 2020
7th Jan 20207:00 amRNSAppointment of Director
17th Dec 20197:00 amRNSPortfolio Company Update: Lucyd
12th Dec 20197:00 amRNSPortfolio Company Update
2nd Dec 20191:09 pmRNSBoard Changes
1st Nov 20197:00 amRNSChange of Adviser
16th Oct 20197:00 amRNSPortfolio Company Update
16th Sep 20199:07 amRNSShare Options
2nd Sep 20197:00 amRNSPortfolio Company Update
22nd Aug 20197:00 amRNSHalf-year Report
15th Aug 20197:00 amRNSPortfolio Update: Lucyd Launches Sherman Shades
12th Aug 20197:00 amRNSSalarius Files Additional Patent for MicroSalt®
6th Aug 20197:00 amRNSBelluscura raises £750,000 of additional funding
5th Aug 20193:21 pmRNSHolding(s) in Company - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.